Summary
Alexis Norris is a bioinformatician with 12 years of experience translating complex genomic, transcriptomic, and metabolomic data into regulatory and clinical insight, currently chairing the FDA Omics Working Group. At the FDA since 2018, she combines hands-on variant discovery and RNA‑seq expertise with policy-focused coordination across omics standards and applications. Her academic work—culminating in a PhD from Johns Hopkins—includes discovery of a novel structural variant in familial pancreatic cancer and multidisciplinary postdoctoral studies in neurodevelopmental disorders. She has taught graduate bioinformatics and biostatistics, founded a nonprofit to bring genomics into high school classrooms, and brings rare experience bridging diagnostic assay development, regulatory science, and outreach.
12 years of coding experience
3 years of employment as a software developer
Doctor of Philosophy (PhD), Cellular and Molecular Medicine (CMM), Doctor of Philosophy (PhD), Cellular and Molecular Medicine (CMM) at The Johns Hopkins University School of Medicine
BS, Molecular Biology and Biochemistry, BS, Molecular Biology and Biochemistry at Millersville University of Pennsylvania
English